• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

碘化钠转运体在人甲状腺良恶性组织中的表达

Expression of sodium iodide symporter in benign and malignant human thyroid tissues.

作者信息

Lin J D, Hsueh C, Chao T C, Weng H F

机构信息

Department of Internal Medicine, Chang Gung Memorial Hospital, Taoyuan, Taiwan, R.O.C.

出版信息

Endocr Pathol. 2001 Spring;12(1):15-21. doi: 10.1385/ep:12:1:15.

DOI:10.1385/ep:12:1:15
PMID:11478264
Abstract

The extent of human sodium iodide symporter (hNIS) expression in different kinds of human thyroid cancer tissues and cell lines remains controversial. In this study, polyclonal antibodies to hNIS were used to analyze the expression of symporter protein in benign and malignant human thyroid tissues. Formalin-fixed, paraffin wax-embedded tissue sections were used. Staining was performed using primary polyclonal antibody of rabbit anti-human hNIS diluted in PBS (1:500). Results showed that 2 of 3 normal tissue, 3 of 6 nodular hyperplasia, one follicular adenoma, 3 of 11 papillary thyroid carcinoma, 1 of 5 follicular carcinoma and none of 3 metastatic thyroid epithelial tissue specimens stained positively for hNIS. A higher percentage of positive staining for symporter protein was found in benign thyroid tissues including normal thyroid tissue, nodular hyperplasia, and adenoma (60%). In contrast, papillary and follicular thyroid carcinomas demonstrated lower symporter protein expression (20%). In conclusion, although the number of tissue samples examined in this study was small, hNIS staining found a higher ratio of symporter protein expression in normal and benign thyroid tissues compared with malignant tissues. Determination of the reason for discrepancies in the expression of hNIS in in vivo and in vitro studies will require further investigation.

摘要

人钠碘转运体(hNIS)在不同类型的人甲状腺癌组织和细胞系中的表达程度仍存在争议。在本研究中,使用针对hNIS的多克隆抗体分析人甲状腺良恶性组织中转运体蛋白的表达。采用福尔马林固定、石蜡包埋的组织切片。使用在PBS中稀释的兔抗人hNIS多克隆一抗(1:500)进行染色。结果显示,3份正常组织中有2份、6份结节性增生中有3份、1份滤泡性腺瘤、11份乳头状甲状腺癌中有3份、5份滤泡癌中有1份以及3份转移性甲状腺上皮组织标本中均未检测到hNIS阳性染色。在包括正常甲状腺组织、结节性增生和腺瘤在内的良性甲状腺组织中,转运体蛋白阳性染色的比例更高(60%)。相比之下,乳头状和滤泡状甲状腺癌的转运体蛋白表达较低(20%)。总之,尽管本研究中检测的组织样本数量较少,但hNIS染色发现正常和良性甲状腺组织中转运体蛋白表达的比例高于恶性组织。体内和体外研究中hNIS表达差异的原因有待进一步研究。

相似文献

1
Expression of sodium iodide symporter in benign and malignant human thyroid tissues.碘化钠转运体在人甲状腺良恶性组织中的表达
Endocr Pathol. 2001 Spring;12(1):15-21. doi: 10.1385/ep:12:1:15.
2
Benign nonfunctioning thyroid adenomas are characterized by a defective targeting to cell membrane or a reduced expression of the sodium iodide symporter protein.良性无功能性甲状腺腺瘤的特征是细胞膜靶向缺陷或钠碘同向转运体蛋白表达降低。
J Clin Endocrinol Metab. 2002 Jan;87(1):352-7. doi: 10.1210/jcem.87.1.8173.
3
Detection of mRNA of sodium iodide symporter in benign and malignant human thyroid tissues.人甲状腺良恶性组织中碘化钠转运体mRNA的检测
Cancer Lett. 2000 Nov 10;160(1):75-80. doi: 10.1016/s0304-3835(00)00565-6.
4
Na+/I- symporter distribution in human thyroid tissues: an immunohistochemical study.钠/碘同向转运体在人甲状腺组织中的分布:一项免疫组织化学研究。
J Clin Endocrinol Metab. 1998 Nov;83(11):4102-6. doi: 10.1210/jcem.83.11.5262.
5
Expression of sodium iodide symporter in metastatic and follicular human thyroid tissues.碘化钠转运体在人甲状腺转移组织和滤泡组织中的表达
Ann Oncol. 2000 May;11(5):625-9. doi: 10.1023/a:1008340402577.
6
Expressions of human sodium iodide symporter mRNA in primary and metastatic papillary thyroid carcinomas.人钠碘同向转运体mRNA在原发性和转移性甲状腺乳头状癌中的表达
Thyroid. 2000 Mar;10(3):211-7. doi: 10.1089/thy.2000.10.211.
7
Evidence for transcriptional and posttranscriptional alterations of the sodium/iodide symporter expression in hypofunctioning benign and malignant thyroid tumors.甲状腺功能减退的良性和恶性甲状腺肿瘤中钠/碘同向转运体表达的转录和转录后改变的证据。
Am J Pathol. 2004 Jul;165(1):25-34. doi: 10.1016/S0002-9440(10)63272-5.
8
Development of reverse transcription-competitive polymerase chain reaction method to quantitate the expression levels of human sodium iodide symporter.
Thyroid. 1999 Apr;9(4):405-9. doi: 10.1089/thy.1999.9.405.
9
Association of low sodium-iodide symporter messenger ribonucleic acid expression in malignant thyroid nodules with increased intracellular protein staining.恶性甲状腺结节中低钠-碘同向转运体信使核糖核酸表达与细胞内蛋白质染色增加的相关性。
J Clin Endocrinol Metab. 2008 Oct;93(10):4141-5. doi: 10.1210/jc.2007-0353. Epub 2008 Jul 15.
10
Analysis of human sodium/iodide symporter, thyroid transcription factor-1, and paired-box-protein-8 gene expression in benign thyroid diseases.良性甲状腺疾病中人类钠/碘同向转运体、甲状腺转录因子-1及配对盒蛋白8基因表达的分析
Thyroid. 1999 May;9(5):455-66. doi: 10.1089/thy.1999.9.455.

引用本文的文献

1
Association between sodium iodide symporter and differentiated Thyroid cancer: a meta-analysis of 9 studies.碘化钠转运体与分化型甲状腺癌之间的关联:9项研究的荟萃分析
Int J Clin Exp Med. 2015 Oct 15;8(10):17986-94. eCollection 2015.

本文引用的文献

1
Radioactive iodine therapy; effect on functioning metastases of adenocarcinoma of the thyroid.放射性碘治疗;对甲状腺腺癌功能性转移灶的影响
J Am Med Assoc. 1946 Dec 7;132(14):838-47. doi: 10.1001/jama.1946.02870490016004.
2
Expression of sodium iodide symporter in metastatic and follicular human thyroid tissues.碘化钠转运体在人甲状腺转移组织和滤泡组织中的表达
Ann Oncol. 2000 May;11(5):625-9. doi: 10.1023/a:1008340402577.
3
Radioisotope concentrator gene therapy using the sodium/iodide symporter gene.
Cancer Res. 1999 Feb 1;59(3):661-8.
4
Na+/I- symporter distribution in human thyroid tissues: an immunohistochemical study.钠/碘同向转运体在人甲状腺组织中的分布:一项免疫组织化学研究。
J Clin Endocrinol Metab. 1998 Nov;83(11):4102-6. doi: 10.1210/jcem.83.11.5262.
5
An immunohistochemical study of Na+/I- symporter in human thyroid tissues and salivary gland tissues.
Endocrinology. 1998 Oct;139(10):4416-9. doi: 10.1210/endo.139.10.6329.
6
Relative value of thallium-201 and iodine-131 scans in the detection of recurrence or distant metastasis of well differentiated thyroid carcinoma.铊-201和碘-131扫描在检测高分化甲状腺癌复发或远处转移中的相对价值
Eur J Nucl Med. 1998 Jul;25(7):695-700. doi: 10.1007/s002590050271.
7
The effects of radioactive iodine in thyroid remnant ablation and treatment of well differentiated thyroid carcinoma.放射性碘在甲状腺残余组织消融及分化型甲状腺癌治疗中的作用。
Br J Radiol. 1998 Mar;71(843):307-13. doi: 10.1259/bjr.71.843.9616241.
8
Analysis of human sodium iodide symporter gene expression in extrathyroidal tissues and cloning of its complementary deoxyribonucleic acids from salivary gland, mammary gland, and gastric mucosa.人甲状腺外组织中碘化钠同向转运体基因表达分析及其唾液腺、乳腺和胃黏膜互补脱氧核糖核酸的克隆
J Clin Endocrinol Metab. 1998 May;83(5):1746-51. doi: 10.1210/jcem.83.5.4839.
9
The sodium iodide symporter: its emerging relevance to clinical thyroidology.
Eur J Endocrinol. 1998 Apr;138(4):374-5. doi: 10.1530/eje.0.1380374.
10
The modulation of the human sodium iodide symporter activity by Graves' disease sera.
J Clin Endocrinol Metab. 1998 Apr;83(4):1217-21. doi: 10.1210/jcem.83.4.4701.